The anti-Trop-2 antibody-drug conjugate Sacituzumab Govitecan-effectiveness, pitfalls and promises.

ABSTRACT:

SUBMITTER: Guerra E 

PROVIDER: S-EPMC9347060 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature